LAB vs PDD · rev $174.4M vs P/E 8.4, rev $61.75B
Standard Biotools Inc (LAB) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
LAB currently screens at market cap $317.1M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the LAB and PDD stock pages for the full models.
Not investment advice.